| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 67 | +62.69% | -1.02% | +0.44% | -1.46% | -4.21% | -0.82 |
| 14d | 67 | +65.67% | -3.04% | +0.64% | -3.51% | -7.58% | -1.71 |
| 30d | 67 | +72.73% | -4.68% | +1.39% | -6.07% | -9.69% | -2.13 |
| 60d | 67 | +71.21% | -6.07% | +2.63% | -8.57% | -14.02% | -2.28 |
| 90d | 67(2 pending) | +64.62% | -6.88% | +4.00% | -11.01% | -18.35% | -2.41 |
| 180d | 67(5 pending) | +58.06% | -9.55% | +8.11% | -17.54% | -20.86% | -4.71 |
| 1y | 67(6 pending) | +73.77% | -15.91% | +18.03% | -33.94% | -40.20% | -9.49 |
| 2y | 67(16 pending) | +94.12% | -42.31% | +40.14% | -82.00% | -89.74% | -26.40 |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 88,424 | — | — | 6,258,287 | Jun 17, 2026 | Jun 22, 2026 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 30,000 | $3.68 | $110.4K | 6,169,863 | Jun 2, 2026 | Jun 4, 2026 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 30,000 | $3.52 | $105.6K | 6,199,863 | May 5, 2026 | May 6, 2026 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 30,000 | $3.10 | $93.0K | 6,229,863 | Apr 7, 2026 | Apr 8, 2026 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 170,000 | $3.46 | $588.2K | 6,259,863 | Mar 3, 2026 | Mar 4, 2026 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 220,000 | $4.20 | $924.0K | 6,429,863 | Feb 3, 2026 | Feb 5, 2026 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 220,000 | $4.36 | $959.2K | 6,649,863 | Jan 6, 2026 | Jan 8, 2026 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 220,000 | $4.37 | $961.4K | 6,869,863 | Dec 2, 2025 | Dec 4, 2025 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 44,031 | — | — | 44,031 | Jun 18, 2025 | Jun 23, 2025 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 22,016 | — | — | 7,089,863 | Jun 18, 2025 | Jun 23, 2025 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 1,734 | — | — | 7,067,847 | Jan 2, 2025 | Jan 6, 2025 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $7.64 | $87.5K | 7,066,113 | Nov 12, 2024 | Nov 14, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $6.72 | $76.9K | 7,077,560 | Oct 29, 2024 | Oct 31, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $6.67 | $76.3K | 7,089,007 | Oct 15, 2024 | Oct 17, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $6.22 | $71.1K | 7,098,428 | Oct 1, 2024 | Oct 3, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 2,026 | — | — | 7,100,454 | Oct 1, 2024 | Oct 4, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $6.84 | $78.3K | 7,109,875 | Sep 17, 2024 | Sep 19, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $6.27 | $71.7K | 7,121,322 | Sep 3, 2024 | Sep 5, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $7.12 | $81.5K | 7,132,769 | Aug 20, 2024 | Aug 22, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $6.82 | $78.1K | 7,144,216 | Aug 6, 2024 | Aug 8, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $8.48 | $97.0K | 7,155,663 | Jul 23, 2024 | Jul 25, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $7.32 | $83.7K | 7,167,110 | Jul 9, 2024 | Jul 11, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 1,441 | — | — | 7,178,557 | Jul 1, 2024 | Jul 3, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $9.51 | $108.8K | 7,177,116 | Jun 25, 2024 | Jun 27, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $8.45 | $96.8K | 7,188,563 | Jun 11, 2024 | Jun 13, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 13,097 | — | — | 7,200,010 | Jun 3, 2024 | Jun 5, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 26,193 | — | — | 26,193 | Jun 3, 2024 | Jun 5, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $9.17 | $104.9K | 7,186,913 | May 28, 2024 | May 30, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 20,054 | $10.12 | $202.9K | 7,198,360 | May 14, 2024 | May 16, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $7.95 | $91.0K | 7,218,414 | Apr 30, 2024 | May 2, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $7.66 | $87.7K | 7,229,861 | Apr 16, 2024 | Apr 18, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $8.82 | $100.9K | 7,241,308 | Apr 2, 2024 | Apr 3, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 20,054 | $10.79 | $216.4K | 7,252,755 | Mar 19, 2024 | Mar 21, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 20,054 | $12.06 | $241.8K | 7,272,809 | Mar 5, 2024 | Mar 6, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 309 | $13.04 | $4.0K | 7,292,863 | Feb 20, 2024 | Feb 21, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 19,745 | $12.31 | $243.1K | 7,293,172 | Feb 20, 2024 | Feb 21, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $9.30 | $106.5K | 7,312,917 | Feb 6, 2024 | Feb 8, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 20,054 | $10.58 | $212.1K | 7,324,364 | Jan 23, 2024 | Jan 25, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 13,751 | $13.81 | $189.9K | 7,344,418 | Jan 9, 2024 | Jan 11, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 6,303 | $13.21 | $83.3K | 7,358,169 | Jan 9, 2024 | Jan 11, 2024 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 20,054 | $10.63 | $213.1K | 7,364,472 | Dec 26, 2023 | Dec 28, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $7.40 | $84.7K | 7,384,526 | Dec 12, 2023 | Dec 14, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE10b5-1 10b5-1 plan | 11,447 | $6.72 | $76.9K | 7,395,973 | Nov 28, 2023 | Nov 30, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $6.32 | $56.2K | 7,407,420 | Nov 14, 2023 | Nov 16, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $5.27 | $46.9K | 7,416,305 | Oct 31, 2023 | Nov 2, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $6.58 | $58.5K | 7,425,190 | Oct 17, 2023 | Oct 19, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $7.29 | $64.8K | 7,434,075 | Oct 3, 2023 | Oct 5, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $8.36 | $74.3K | 7,442,960 | Sep 19, 2023 | Sep 21, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $8.79 | $78.1K | 7,451,845 | Sep 5, 2023 | Sep 7, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $8.91 | $79.2K | 7,460,730 | Aug 22, 2023 | Aug 24, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 3,272 | $11.75 | $38.4K | 7,469,615 | Aug 8, 2023 | Aug 10, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 14,498 | $11.03 | $159.8K | 7,472,887 | Aug 8, 2023 | Aug 10, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 18,719 | $14.61 | $273.5K | 7,487,385 | Jul 25, 2023 | Jul 27, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALEGRANT Gift | 14,000 | — | — | 7,506,104 | Jun 29, 2023 | Jul 27, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $7.39 | $65.6K | 7,528,989 | Jun 27, 2023 | Jun 29, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 12,612 | — | — | 7,537,874 | Jun 16, 2023 | Jun 21, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 25,224 | — | — | 25,224 | Jun 16, 2023 | Jun 21, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 15,485 | $9.98 | $154.5K | 7,525,262 | Jun 13, 2023 | Jun 15, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $8.79 | $78.1K | 7,540,747 | May 30, 2023 | Jun 1, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $5.09 | $45.2K | 7,549,632 | May 16, 2023 | May 17, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $5.93 | $52.7K | 7,558,517 | Apr 18, 2023 | Apr 20, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $6.53 | $58.0K | 7,567,402 | Apr 4, 2023 | Apr 6, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $7.40 | $65.7K | 7,576,287 | Mar 21, 2023 | Mar 23, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $8.33 | $74.0K | 7,585,172 | Mar 7, 2023 | Mar 9, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $7.73 | $68.7K | 7,594,057 | Feb 21, 2023 | Feb 23, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $8.81 | $78.3K | 7,602,942 | Feb 7, 2023 | Feb 9, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $8.71 | $77.4K | 7,611,827 | Jan 24, 2023 | Jan 26, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $7.69 | $68.3K | 7,620,712 | Jan 10, 2023 | Jan 12, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 1,325 | — | — | 7,629,597 | Jan 3, 2023 | Jan 5, 2023 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $7.25 | $64.4K | 7,628,272 | Dec 27, 2022 | Dec 29, 2022 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $8.96 | $79.6K | 7,637,157 | Dec 13, 2022 | Dec 15, 2022 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 8,885 | $8.75 | $77.8K | 7,646,042 | Nov 29, 2022 | Dec 1, 2022 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 17,770 | $11.12 | $197.6K | 7,654,927 | Nov 16, 2022 | Nov 18, 2022 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 920 | — | — | 7,672,697 | Oct 3, 2022 | Oct 5, 2022 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 1,186 | — | — | 7,671,777 | Jul 1, 2022 | Jul 6, 2022 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 18,145 | — | — | 7,670,591 | Jun 14, 2022 | Jun 16, 2022 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 36,290 | — | — | 36,290 | Jun 14, 2022 | Jun 16, 2022 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 1,300 | — | — | 7,652,446 | Apr 1, 2022 | Apr 5, 2022 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 9,625 | $18.03 | $173.5K | 7,651,146 | Jan 4, 2022 | Jan 5, 2022 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 555 | — | — | 7,660,771 | Jan 3, 2022 | Jan 5, 2022 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 9,625 | $18.75 | $180.5K | 7,660,216 | Dec 21, 2021 | Dec 23, 2021 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 7,725 | $20.38 | $157.5K | 7,670,241 | Dec 7, 2021 | Dec 9, 2021 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 400 | $21.03 | $8.4K | 7,669,841 | Dec 7, 2021 | Dec 9, 2021 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 1,500 | $19.78 | $29.7K | 7,677,966 | Dec 7, 2021 | Dec 9, 2021 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 7,725 | $19.05 | $147.2K | 7,679,466 | Nov 18, 2021 | Nov 22, 2021 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 1,900 | $18.32 | $34.8K | 7,687,191 | Nov 18, 2021 | Nov 22, 2021 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 457 | — | — | 7,689,091 | Oct 1, 2021 | Oct 5, 2021 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 278 | — | — | 7,688,634 | Jul 1, 2021 | Jul 6, 2021 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASE | 12,500 | — | — | 12,500 | Apr 20, 2021 | Apr 22, 2021 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 12,500 | — | — | 0 | Apr 20, 2021 | Apr 22, 2021 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 7,688,356 | — | — | 0 | Apr 20, 2021 | Apr 22, 2021 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 378,309 | — | — | 0 | Apr 20, 2021 | Apr 22, 2021 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASE | 7,688,356 | — | — | 7,688,356 | Apr 20, 2021 | Apr 22, 2021 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASE | 923,052 | — | — | 7,688,356 | Apr 20, 2021 | Apr 22, 2021 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | SALE | 544,743 | — | — | 0 | Apr 20, 2021 | Apr 22, 2021 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 6,250 | — | — | 6,765,304 | Apr 16, 2021 | Apr 19, 2021 ↗ | View → |
| RXRX RECURSION PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 12,500 | — | — | 12,500 | Apr 15, 2021 | Apr 19, 2021 ↗ | View → |